Venus Medtech (Hangzhou) Inc. (HKG:2500)
Hong Kong
· Delayed Price · Currency is HKD 1.860
+0.010 (0.54%)
Apr 29, 2026, 4:08 PM HKT
Venus Medtech (Hangzhou) Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Revenue | 306.79 | 470.83 | 491.37 | 406.46 | 415.86 | Upgrade
|
| Revenue Growth (YoY) | -34.84% | -4.18% | 20.89% | -2.26% | 50.65% | Upgrade
|
| Cost of Revenue | 94.95 | 103.09 | 102.17 | 92.46 | 91.52 | Upgrade
|
| Gross Profit | 211.83 | 367.75 | 389.21 | 314 | 324.34 | Upgrade
|
| Selling, General & Admin | 292.24 | 391.09 | 454.26 | 436.76 | 344.65 | Upgrade
|
| Research & Development | 267.4 | 341.19 | 524.92 | 527.45 | 258.34 | Upgrade
|
| Other Operating Expenses | - | - | - | 21.97 | 3.19 | Upgrade
|
| Operating Expenses | 557.15 | 733.37 | 977.75 | 986.18 | 606.17 | Upgrade
|
| Operating Income | -345.32 | -365.62 | -588.55 | -672.19 | -281.83 | Upgrade
|
| Interest Expense | -17.81 | -16.65 | -62.72 | -44.62 | -1.91 | Upgrade
|
| Interest & Investment Income | 5.02 | 10.35 | 34.46 | 34.65 | 49.48 | Upgrade
|
| Earnings From Equity Investments | -2.1 | -4.15 | -12.38 | -13.94 | -11.71 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.88 | 2.26 | 81.73 | 10.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -59.54 | -222.08 | -65.7 | -104.45 | -145.84 | Upgrade
|
| EBT Excluding Unusual Items | -419.76 | -597.28 | -692.63 | -718.82 | -381.79 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -15.8 | - | Upgrade
|
| Impairment of Goodwill | - | - | -231.26 | -304.3 | -189.96 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -81.41 | 45.48 | -5.69 | 1.33 | Upgrade
|
| Asset Writedown | - | -62.03 | -17.52 | -111.74 | -46.19 | Upgrade
|
| Other Unusual Items | 14.87 | - | 160.59 | - | 239.05 | Upgrade
|
| Pretax Income | -404.89 | -740.71 | -735.34 | -1,156 | -377.56 | Upgrade
|
| Income Tax Expense | 2.81 | -23.34 | -6.28 | -34.3 | -6.16 | Upgrade
|
| Earnings From Continuing Operations | -407.69 | -717.37 | -729.06 | -1,122 | -371.39 | Upgrade
|
| Minority Interest in Earnings | - | 3.07 | 25.3 | 64.34 | -2.24 | Upgrade
|
| Net Income | -407.69 | -714.31 | -703.75 | -1,058 | -373.64 | Upgrade
|
| Net Income to Common | -407.69 | -714.31 | -703.75 | -1,058 | -373.64 | Upgrade
|
| Shares Outstanding (Basic) | 438 | 438 | 438 | 438 | 439 | Upgrade
|
| Shares Outstanding (Diluted) | 438 | 438 | 438 | 438 | 439 | Upgrade
|
| Shares Change (YoY) | - | - | - | -0.15% | 7.16% | Upgrade
|
| EPS (Basic) | -0.93 | -1.63 | -1.61 | -2.42 | -0.85 | Upgrade
|
| EPS (Diluted) | -0.93 | -1.63 | -1.61 | -2.42 | -0.85 | Upgrade
|
| Free Cash Flow | - | -10.18 | -870.66 | -899.44 | -538.99 | Upgrade
|
| Free Cash Flow Per Share | - | -0.02 | -1.99 | -2.05 | -1.23 | Upgrade
|
| Gross Margin | 69.05% | 78.11% | 79.21% | 77.25% | 77.99% | Upgrade
|
| Operating Margin | -112.56% | -77.65% | -119.78% | -165.38% | -67.77% | Upgrade
|
| Profit Margin | -132.89% | -151.71% | -143.22% | -260.22% | -89.85% | Upgrade
|
| Free Cash Flow Margin | - | -2.16% | -177.19% | -221.28% | -129.61% | Upgrade
|
| EBITDA | -315.42 | -335.73 | -547.66 | -591.19 | -247.4 | Upgrade
|
| EBITDA Margin | -102.81% | -71.30% | -111.46% | -145.45% | -59.49% | Upgrade
|
| D&A For EBITDA | 29.89 | 29.89 | 40.88 | 80.99 | 34.43 | Upgrade
|
| EBIT | -345.32 | -365.62 | -588.55 | -672.19 | -281.83 | Upgrade
|
| EBIT Margin | -112.56% | -77.65% | -119.78% | -165.38% | -67.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.